Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IP2015 ID Capsaicin Model Study
NCT05181852Phase 1Unknown
- Sponsor
- Initiator Pharma A/S
- Start
- Jan 2022
- Primary completion
- May 2022
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial of pudafensine in neuropathic pain (4 arms), sponsored by Initiator Pharma A/S. Primary endpoint: Pain related assessments of effect. Status: unknown.
02
Drugs
pudafensine
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT05181852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05181852.